Cargando…
Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic Implications
[Image: see text] The binding processes of two Polo-like kinase inhibitors, RO3280 and GSK461364, to the human serum albumin (HSA) protein as well as the protonation equilibria of both compounds have been studied combining absorbance and fluorescence spectroscopy experiments together with density fu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997069/ https://www.ncbi.nlm.nih.gov/pubmed/36812406 http://dx.doi.org/10.1021/acs.molpharmaceut.2c00849 |
_version_ | 1784903183802302464 |
---|---|
author | Fernández-Sainz, Jesús Pacheco-Liñán, Pedro J. Ripoll, Consuelo González-Fuentes, Joaquín Albaladejo, José Bravo, Iván Garzón-Ruiz, Andrés |
author_facet | Fernández-Sainz, Jesús Pacheco-Liñán, Pedro J. Ripoll, Consuelo González-Fuentes, Joaquín Albaladejo, José Bravo, Iván Garzón-Ruiz, Andrés |
author_sort | Fernández-Sainz, Jesús |
collection | PubMed |
description | [Image: see text] The binding processes of two Polo-like kinase inhibitors, RO3280 and GSK461364, to the human serum albumin (HSA) protein as well as the protonation equilibria of both compounds have been studied combining absorbance and fluorescence spectroscopy experiments together with density functional theory calculations. We found that the charge states of RO3280 and GSK461364 are +2 and +1, respectively, at the physiological pH. Nevertheless, RO3280 binds to HSA in the charge state +1 prior to a deprotonation pre-equilibrium. Binding constants to site I of HSA of 2.23 × 10(6) and 8.80 × 10(4) M(–1) were determined for RO3280 and GSK461364, respectively, at 310 K. The binding processes of RO3280 and GSK461364 to HSA are entropy- and enthalpy-driven, respectively. The positive enthalpy found for the RO3280-HSA complex formation could be related to a proton pre-equilibrium of RO3280. |
format | Online Article Text |
id | pubmed-9997069 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-99970692023-03-10 Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic Implications Fernández-Sainz, Jesús Pacheco-Liñán, Pedro J. Ripoll, Consuelo González-Fuentes, Joaquín Albaladejo, José Bravo, Iván Garzón-Ruiz, Andrés Mol Pharm [Image: see text] The binding processes of two Polo-like kinase inhibitors, RO3280 and GSK461364, to the human serum albumin (HSA) protein as well as the protonation equilibria of both compounds have been studied combining absorbance and fluorescence spectroscopy experiments together with density functional theory calculations. We found that the charge states of RO3280 and GSK461364 are +2 and +1, respectively, at the physiological pH. Nevertheless, RO3280 binds to HSA in the charge state +1 prior to a deprotonation pre-equilibrium. Binding constants to site I of HSA of 2.23 × 10(6) and 8.80 × 10(4) M(–1) were determined for RO3280 and GSK461364, respectively, at 310 K. The binding processes of RO3280 and GSK461364 to HSA are entropy- and enthalpy-driven, respectively. The positive enthalpy found for the RO3280-HSA complex formation could be related to a proton pre-equilibrium of RO3280. American Chemical Society 2023-02-22 /pmc/articles/PMC9997069/ /pubmed/36812406 http://dx.doi.org/10.1021/acs.molpharmaceut.2c00849 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Fernández-Sainz, Jesús Pacheco-Liñán, Pedro J. Ripoll, Consuelo González-Fuentes, Joaquín Albaladejo, José Bravo, Iván Garzón-Ruiz, Andrés Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic Implications |
title | Unusually High Affinity of the PLK Inhibitors RO3280
and GSK461364 to HSA and Its Possible Pharmacokinetic Implications |
title_full | Unusually High Affinity of the PLK Inhibitors RO3280
and GSK461364 to HSA and Its Possible Pharmacokinetic Implications |
title_fullStr | Unusually High Affinity of the PLK Inhibitors RO3280
and GSK461364 to HSA and Its Possible Pharmacokinetic Implications |
title_full_unstemmed | Unusually High Affinity of the PLK Inhibitors RO3280
and GSK461364 to HSA and Its Possible Pharmacokinetic Implications |
title_short | Unusually High Affinity of the PLK Inhibitors RO3280
and GSK461364 to HSA and Its Possible Pharmacokinetic Implications |
title_sort | unusually high affinity of the plk inhibitors ro3280
and gsk461364 to hsa and its possible pharmacokinetic implications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997069/ https://www.ncbi.nlm.nih.gov/pubmed/36812406 http://dx.doi.org/10.1021/acs.molpharmaceut.2c00849 |
work_keys_str_mv | AT fernandezsainzjesus unusuallyhighaffinityoftheplkinhibitorsro3280andgsk461364tohsaanditspossiblepharmacokineticimplications AT pachecolinanpedroj unusuallyhighaffinityoftheplkinhibitorsro3280andgsk461364tohsaanditspossiblepharmacokineticimplications AT ripollconsuelo unusuallyhighaffinityoftheplkinhibitorsro3280andgsk461364tohsaanditspossiblepharmacokineticimplications AT gonzalezfuentesjoaquin unusuallyhighaffinityoftheplkinhibitorsro3280andgsk461364tohsaanditspossiblepharmacokineticimplications AT albaladejojose unusuallyhighaffinityoftheplkinhibitorsro3280andgsk461364tohsaanditspossiblepharmacokineticimplications AT bravoivan unusuallyhighaffinityoftheplkinhibitorsro3280andgsk461364tohsaanditspossiblepharmacokineticimplications AT garzonruizandres unusuallyhighaffinityoftheplkinhibitorsro3280andgsk461364tohsaanditspossiblepharmacokineticimplications |